EAM Investors’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-57,216
| Closed | -$2.92M | – | 281 |
|
|
2024
Q3 | $2.92M | Buy |
57,216
+37
| +0.1% | +$1.89K | 0.44% | 124 |
|
|
2024
Q2 | $2.56M | Sell |
57,179
-49,435
| -46% | -$2.21M | 0.42% | 124 |
|
|
2024
Q1 | $4.99M | Buy |
106,614
+1,609
| +2% | +$75.3K | 0.78% | 13 |
|
|
2023
Q4 | $3.74M | Buy |
105,005
+10,816
| +11% | +$385K | 0.66% | 52 |
|
|
2023
Q3 | $2.8M | Buy |
+94,189
| New | +$2.8M | 0.54% | 42 |
|
|
2022
Q1 | – | Sell |
-66,948
| Closed | -$1.9M | – | 303 |
|
|
2021
Q4 | $1.9M | Buy |
+66,948
| New | +$1.9M | 0.31% | 139 |
|